View more on these topics

Sitka VCT offering 10 million C1 shares

Sitka health fund VCT is offering 10 million C1 fund shares for 1 each, hoping to double its size to 20m.

The VCT, which has been established since 2001, aims to provide dividends through inv-esting in firms with a defined exit horizon of two to four years, whether through Aim flotation or sale to trade buyers.

The VCT is currently inves-ted in 13 companies, from those developing cardiac monitoring devices through fertility diagnostics and drug-testing services to day-surgery companies.

The average investment is 500,000. Of companies in the VCT, one recorded a successful Aim listing in 2004 and another was acquired by a trade buyer earlier this year. Two more companies intend to float on Aim this year and two more firms are in discussions for trade sale this year.

Joint managing partner Louis Nisbet says: “In terms of risk, healthcare does not des-erve to be quoted in the same terms as, for example, media, luxury goods or information technology. Healthcare is centuries old – the market is always there and always will be there.”

Recommended

Invesco Perpetuals Aim VCT to close early

The Invesco Perpetual Aim VCT is to close early to protect existing investors, having raised 9.86 million and invested in 32 companies to date.The NAV of the VCT at February 28 20005 was 118.66p per share, compared with the current subscription price of 1 per share. The fund is managed by Andy Crossley.

Bright Grey scoops four honours at LifeSearch Protection Awards

Bright Grey is celebrating its success in this year’s LifeSearch Protection Awards, picking up four awards.The awards were for best critical illness product, most improved provider, best new initiative, for the second year runing, and lastly, best press office. David Robinson, chief executive of Bright Grey David Robinson says: “To be short-listed for nine of […]

The Rubik’s Cube: China’s policy trilemma

By Douglas Turnbull, Investment Director, Head of Chinese Equities China faces a ‘Rubik’s Cube’ policy trilemma, whereby it needs to sustain a minimum acceptable level of growth, deal with issues such as overcapacity and reform the financial system to make it a far more efficient allocator of capital. Given the contradictory nature of these objectives, […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment